Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ARNA 6.17 +0.01 (0.16%)
price chart
Arena Pharmaceuticals' Belviq Sales Dip - Why?
Belviq, the anti-obesity drug from Arena Pharmaceuticals (ARNA), saw sales fall over 10% last week according to industry tracking services IMS Health and Symphony Health.
Special News Alert: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Incyte ...  Market News Call
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): Success On The Back Of Anti ...
However, the saving grace for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Eisai is the extension of the discount. With television ads ready to be launched, there will be a course correction over the next few weeks.
Arena Pharmaceuticals Now Covered by Wells Fargo & Co. (ARNA)  Watch List News (press release)
Related articles »  
Interesting ARNA Put And Call Options For June 6th
Investors in Arena Pharmaceuticals Inc (Symbol: ARNA) saw new options begin trading today, for the June 6th expiration. At Stock Options Channel , our YieldBoost formula has looked up and down the ARNA options chain for the new June 6th contracts and ...
Related articles »  
Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ� (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management.
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): TV Ads For Belviq Launched
Dallas, Texas 04/17/2014 (ustradevoice) - One of the main reasons, analysts and pundits say, why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has not had success with its FDA-approved weight management drug known as Belviq, is lack of awareness.
Small Cap Recent Insider Selling: Arena Pharmaceuticals (NASDAQ:ARNA ...  Tech News
Biotech recent insider selling: Arena Pharmaceuticals (NASDAQ:ARNA ...  Gaining Green
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The Future Is Encouraging
That being the case, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) seems to have come to the realization that unless it takes proactive steps to expand the market share of its anti-obesity drug Belviq, it might as well miss out on a great opportunity.
Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Idera ...
Lakeway, NY - (MARKET NEWS CALL) - 4/23/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Investor's Watch List - Inovio Pharmaceuticals Inc (INO), Arena ...  Techsonian (press release)
Related articles »  
Traders Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Hecla ...
Lakeway, NY - (MARKET NEWS CALL) - 4/24/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Latest Developments: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Illumina, Inc ...
Latest Developments: Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), Illumina, Inc. (NASDAQ:ILMN), Arena Pharmaceuticals, Inc. (NASDAQ: ARNA). By hotstockprofits � April 24, 2014 �. New York, NY - (MARKET NEWS CALL) - 4/24/2014� Ariad ...
Related articles »  
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL ...
Free technical research on ARNA, CELG, PDLI and HEB can be downloaded upon signing up at: http://www.investor-edge.com/905-register On Monday, shares in Arena Pharmaceuticals Inc. gained 2.57% to close the day at $6.38. The stock recorded a ...
Related articles »